Pharmaceutical giant Pfizer (PFE) has named company veteran Chris Boshoff its chief of research and development (R&D) as it ...

Pfizer has found a successor for retiring Chief Scientific Officer and R&D head Mikael Dolsten, M.D., Ph.D., tapping the ...

Chris Boshoff will take on the role of chief scientific officer starting Jan 1 & oversee all functions of research & ...

Recent developments in health news highlight the CDC's anticipation of increased COVID-19 and RSV cases during the holidays, ...

Pfizer has appointed Chris Boshoff, its current chief oncology officer and executive vice president, as chief scientific ...

Company veteran Chris Boshoff, who has led Pfizer’s cancer research and marketing for more than a year, will become chief ...

Pfizer Inc. (NYSE: PFE) today announced that after a comprehensive internal and external selection process, the company is ...

"Dr Boshoff is the ideal leader to propel Pfizer's R&D engine forward and transform it into a world-leading organisation with ...

Pfizer Inc. (NYSE: PFE) today announced that after a comprehensive internal and external selection process, the company is appointing Chris Boshoff ...

The WHO approved KM Biologics' mpox vaccine for emergency use. The US CDC predicts a rise in COVID-19 and RSV cases. Pfizer ...

As for his soon-to-be former role, Boshoff will be succeeded by Dr. Roger Dansey, who will serve as the interim chief ...

Chris Boshoff will replace Mikael Dolsten, who’s stepping down after 15 years leading research at the drugmaker.